John N. Constantino is a board-certified child and adolescent psychiatrist and chief of behavioral and mental Health at Children’s Healthcare of Atlanta, as well as professor of psychiatry and pediatrics at Emory University School of Medicine. He is an international leader in autism trait phenotyping, sex differences in autism, and endophenotypic analyses.
John Constantino
Chief of behavioral and mental health
Children’s Healthcare of Atlanta
From this contributor
By
Sneha Chaturvedi, John Constantino, Natasha Marrus, Sven Sandin, Benjamin Yip
19 September 2024
6 min read
Autism is more heritable in boys than in girls
If boys have greater inherited liability for autism, the female protective effect may not fully explain the sex difference in prevalence.
Autism is more heritable in boys than in girls
By
Sneha Chaturvedi, John Constantino, Natasha Marrus, Sven Sandin, Benjamin Yip
19 September 2024 | 6 min read
Q&A with John Constantino: Solving the biomarker conundrum
Biological factors that reflect autism’s roots may differ from those that influence how severe the condition is. Failure to make a distinction has stymied the search for biomarkers.
Q&A with John Constantino: Solving the biomarker conundrum
By
Alla Katsnelson
3 August 2021 | 7 min read
Traits of other conditions may spur autism
Early features of other conditions may contribute to autism itself
Traits of other conditions may spur autism
By
John Constantino, Zoë Hawks
12 June 2018 | 7 min read
Japanese spectrum
Researchers studying autism prevalence should take into account the continuous nature of autism symptoms in the general population, says John Constantino.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read